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Visual field (VF) analysis is a key component of the evaluation and management of glaucoma, a chronic optic neuropathy marked by progressive retinal ganglion cell degeneration and associated VF constriction that is the leading cause of irreversible blindness worldwide. 1, 2 Ophthalmologists have long observed that glaucoma tends to present with a characteristic set of VF defect patterns, which anatomically correspond to loss of particular optic nerve axon bundles. 1 In addition to differing in corresponding anatomic changes, distinct glaucomatous VF defect categories have also been found to differ in associated risk factors, genetic predispositions, pathophysiologic etiologies, and functional impairment, with important implications for glaucoma subtyping and targeted screening and therapy. [3] [4] [5] [6] [7] [8] [9] Glaucoma diagnosis, monitoring, and pathophysiologic elucidation would thus all benefit from a reproducible system for characterizing and longitudinally tracking a patient's VF defect patterns over time.
Historically, descriptions of VF defect patterns in patients with glaucoma have been based on qualitative consensus among cliniciansfor example, Keltner et al. characterized 17 mutually exclusive VF defect pattern categories (including both glaucomatous and nonglaucomatous etiologies) based on expert clinician analysis of the VFs with which glaucoma suspects and patients presented in the Ocular Hypertension Treatment Study. 10 Common qualitative terminology applied to glaucomatous-appearing VF defect patterns include paracentral (localized VF loss generally within 15° of fixation, where degrees are the unit of measurement of the visual angle, or angle that a part of the VF subtends on an observer's retina), peripheral (VF loss that is not paracentral), arcuate (arclike VF loss extending from the blind spot around fixation to the nasal horizontal meridian), nasal step (localized peripheral VF loss adjacent to the nasal horizontal meridian), temporal wedge (localized VF loss temporal to the physiologic blind spot), and central island (global VF constriction sparing fixation found in end-stage glaucoma). 10 It is also often useful to specify whether glaucomatous-appearing VF loss predominantly affects the superior or inferior VF hemifield, as glaucoma has been observed to tend to asymmetrically affect the superior and inferior VF hemifields. 11 Despite the utility and long history of qualitative VF classification systems, a quantitative VF classification system offers the potential advantages of better reproducibility, objectivity, and capacity to partition complex VF defects into multiple components associated with both glaucomatous and non-glaucomatous etiologies. 1 There has been special interest recently in developing quantitative VF classification systems using unsupervised statistical learning methods, where a computer algorithm is used to reveal patterns in VF data without requiring input from clinical diagnostic experience. [12] [13] [14] [15] [16] To date, the three most commonly applied unsupervised statistical learning-based VF classification methods have been: (1) cluster analysis, where VFs are grouped into clusters that each include VFs more similar to each other than to VFs from other clusters (for example, a three-cluster solution featuring a cluster of normal-appearing VFs, a cluster of VFs representing mild glaucoma, and a cluster of VFs representing more severe glaucoma); (2) component analysis, where VF data are treated as a multidimensional space that can be projected onto axes that capture some intrinsic structure to the VF data (for example, an axis representing superior versus inferior VF loss, an axis representing temporal versus nasal VF loss, and an axis representing central versus peripheral VF loss); and (3) a hybrid of cluster and component analyses,
where VFs are first grouped into clusters, after which axes are identified for each cluster. [12] [13] [14] [15] [16] Previously published approaches to quantitative VF classification have had a few notable limitations. 20 According to this framework, the criterion validity of VF archetypal analysis is supported by VF ATs' resemblance to previously described qualitative VF defect patterns. 10 The content validity of VF archetypal analysis is supported by inclusion of a complete set of potential underlying etiologies for VF ATs. Finally, the construct validity of VF archetypal analysis has not yet been demonstrated and is hence the subject of the present study.
In this retrospective study, I hypothesized that 
Section 2. Methods
The Massachusetts Eye and Ear Infirmary (MEEI) Institutional Review Board approved this study.
Section 2.1. Visual field archetypal decomposition and study population selection
The previously described VF archetypal decomposition algorithm was applied to 30,995 reliable (fixation loss rate ≤33% and false-positive and false-negative rates ≤20%) consecutive
Humphrey VFs (24-2 SITA standard algorithm) recorded between January 2007 and October 2013 on the MEEI Glaucoma Service Humphrey Field Analyzers (HFA-II, Carl Zeiss Meditec AG, Jena, Germany). 17 Figure 2 Tables 1 and   2 . Glaucoma diagnoses were based on clinician assessments, except for patients with AT1 (no focal defect), who were at most considered glaucoma suspects in this study due to absence of VF loss. CDRs were based on clinician assessments, as optic disc photos were inconsistently available for confirmation. Current intraocular pressure (IOP) and central corneal thickness (CCT) were excluded for patients with history of corneal procedures, which may have modified these measurements.
The clinical characteristics included for analysis in this study were selected based on (1) literature review of systemic and ocular parameters previously suggested to play a role in risk of development and/or progression of glaucoma and (2) availability and standardization of documentation of data. Thus, while preliminary data were collected on multiple other potentially interesting clinical features, these were ultimately excluded from analysis because of inconsistencies in availability or reliability of documentation.
Section 2.3. Statistical analysis
Descriptive statistics of baseline characteristics were generated for each AT. For the categories of chart-documented race and glaucoma diagnosis, only patients with a single documented race or glaucoma diagnosis category were included in analysis. Mean values or percentages of continuous or categorical data respectively were compared in turn between each AT and all other VF ATs combined using the two-tailed Student t-test or Fisher exact test respectively. This method of statistical comparison was chosen to help identify features that distinguish particular VF ATs from all others, which is more useful and less subject to false positive results than an alternative method of testing for all possible pairwise differences in clinical characteristics across ATs. P<0.05 was defined as statistically significant. All analyses were performed using the Stata statistical package, version 12.1 (StataCorp LP, College Station, Texas, USA).
Section 3. Results
Key systemic, VF, and ocular baseline characteristics of our study population are summarized in Table 1 . Statistically significant distinguishing characteristics for each AT are summarized in Table 2 . al. 17 The low mean PSDs in AT1 (no focal defect) and AT6 (central island) are consistent with the concept that PSD will be low in both cases of minimal VF loss and cases of diffuse VF loss (where VF sensitivities at particular points in the VF testing field become harder to differentiate from surrounding points because of the globally depressed VF sensitivities).
The GHT was developed to help predict the likelihood that a VF defect pattern is glaucomatous in etiology by assessing for asymmetry in VF loss between the superior and inferior hemifields, based on the observation that glaucoma tends to asymmetrically involve these hemifields. 11 The high percentage of patients with GHT results outside normal limits (reflecting likelyglaucomatous VF defect patterns) in most ATs is consistent with the high percentage of patients carrying glaucoma diagnoses in this patient cohort. Conversely, the high percentage of patients with GHT results within normal limits in AT1 (no focal defect) is consistent with the absence of VF defect in this AT.
Of note, the high percentage of patients with GHT results within normal limits in AT4 (temporal wedge defect) is corroborated by the significantly lower mean CDR and lower percentage of patients with CDR≥0.7 in this AT, which may suggest a predominantly nonglaucomatous etiology to AT4 (temporal wedge defect). Although isolated temporal wedge defects have been previously reported in association with glaucoma, important alternative etiologies of blind spot enlargement include peripapillary atrophy and tilted discs particularly in association with myopia, chorioretinal disease (notably, multiple evanescent white dot syndrome), optic disc swelling, optic nerve head drusen, and idiopathic blind spot enlargement syndrome. 23-31 I was not able to adequately assess these potential etiologies of AT4 (temporal wedge defect) in the present study, but did find a trend toward a higher percentage of myopic patients in this AT in preliminary analysis (not shown) of spherical equivalent refractive errors based on documented corrective lens prescriptions available for 181 phakic patients (patients with intact natural lens; the refractive error in post-cataract-surgery patients is affected by the power of the implanted artificial intraocular lens). Follow-up research with more complete data on manifest spherical equivalent refractive errors (optimal refractions formally measured using a phoropter, which are more accurate than potentially outdated corrective lenses prescriptions) is necessary to more definitively assess potential correlations between certain ATs and refractive errors. It would also be useful in the future to use optic disc photos (insufficiently available for the present study cohort) to test for an association between AT4 (temporal wedge defect) and peripapillary atrophy or tilted discs.
CDR is an important component of screening, diagnosis, and monitoring of glaucoma. Although glaucomatous optic nerve appearance has been recently shown to be better captured by parameters like the Disc Damage Likelihood Scale (DDLS), which takes into account the absolute optic disc diameter (since a larger CDR in a smaller optic disc is more concerning for retinal ganglion cell loss) and eccentricity of neuroretinal rim thinning (reflective of the focal retinal ganglion cell loss characteristic of early glaucoma), CDR alone is still widely reported by clinicians and in the published literature and is particularly useful in the present study due to the absence of optic disc photos for standardized evaluation of optic disc size and focal neuroretinal rim thinning. [32] [33] [34] [35] The CDR distributions across VF ATs support the construct validity of VF archetypal analysis by highlighting several VF defect patterns that are clinically expected to be glaucomatous or nonglaucomatous in etiology. In particular, mean CDR was significantly lower than in other ATs (and less likely to be ≥0.7) in AT1 (no focal defect), AT2 (superior defect;
further associated with the expected nonglaucomatous etiology of lid ptosis), AT4 (temporal wedge defect; discussed above), and AT9 (inferotemporal defect; to my knowledge not previously reported in the literature to be associated with glaucoma). Conversely, the percentage of patients with CDR≥0.7 was significantly higher than in other ATs in AT6 (central island;
known to represent advanced glaucomatous VF loss) and AT14 and AT16 (superior and inferior paracentral defects respectively; well-studied VF defect patterns associated with glaucoma). 4-6, 36, 37 Other associations consistent with clinical expectations include: AT7 (central scotoma) and AT13 (diffuse inferior defect) and worse BCVA, consistent with the involvement of central fixation in both of these VF ATs; AT12 (temporal hemianopia) and history of strokethe lack of an association between AT15 (nasal hemianopia) and history of stroke may be in part due to the smaller sample size of patients with AT15 (nasal hemianopia) in this study cohort; and the trend toward an association between AT11 (peripheral rim defect) and VF trial lens spherical equivalent refractive error >6D (previously reported to cause lens rim artifact). 22, 38, 39 The female predominance among patients with AT16 (inferior paracentral defect) in our study cohort is consistent with estrogen's known role in modulating endothelial nitric oxide synthase Caucasian counterparts, likely mediated at least in part by underlying genetic differences. [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] Numerous studies have documented the highest prevalences of glaucoma overall and by age decade among people of African ancestry, with the most pronounced prevalence gaps between those of African and European ancestry at younger ages. [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] Patients with POAG of African ancestry may also have a higher likelihood of rapid VF deterioration than those who are Caucasian. 63 [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] In concert with these parameters, elevated IOP is a welldocumented risk factor for progressive VF field loss or presentation with advanced glaucoma among patients of many ancestries. [81] [82] [83] [84] [85] The association of AT6 with elevated current IOP in our study may reflect some combination of physiological barriers to IOP control and socioeconomic barriers to glaucoma treatment adherence. [86] [87] [88] [89] [90] Fuller characterization of patients with the AT6 (central island) pattern of VF loss may aid development of targeted glaucoma screening and management protocols for those most at risk for advanced glaucomatous VF loss.
Section 4.2. Findings that have not been previously reported in the literature
Like AT6 (central island), AT13 (diffuse inferior defect), another functionally debilitating glaucomatous VF defect pattern due to its correlation with poor BCVA, increased fall risk, and poor overall functional status, was also associated with African ancestry in our study cohortan association that to my knowledge is new to the literature. 7, 8 The correlation suggested by the present study between AT13 (diffuse inferior defect) and CACG has also not been previously reported. The few existing studies characterizing VF defect patterns associated with CACG suggest more generalized VF loss and less paracentral VF involvement in CACG than in POAG, as well as increased susceptibility to superior than inferior VF loss. [91] [92] [93] [94] [95] There may be particular need for better future characterization of patterns of CACG presentation in racially heterogeneous populations, as most previous research characterizing CACG-related VF defect patterns has focused on Asian patient populations, in whom CACG is known to be highest in prevalence. 56 AT9 (inferotemporal defect), to my knowledge, has not been previously described in the literature in association with glaucoma or other optic neuropathies. Its association with lower mean CDR and lower likelihood of CDR≥0.7, younger age (particularly <40 years), and Asian race in our study population may reflect a predominantly nonglaucomatous etiology. Among candidate etiologies, myopia is a particularly interesting possibility; myopia has been previously shown to be associated with nasal retinal nerve fiber layer (RNFL) thinning and temporal VF defects, perhaps mediated by peripapillary atrophy and/or optic disc tilt and torsion. [96] [97] [98] [99] [100] In preliminary analysis of spherical equivalent refractive errors similar to that described above for AT4 (temporal wedge defect), patients with AT9 (inferotemporal defect) trended toward being more likely to be myopic in our study cohort. I did not have access to enough fundus images in this study to specifically test for associations with peripapillary atrophy or optic disc tilt and torsion, but these would be worth examining in the future.
Section 4.3. Limitations and strengths
This study has several limitations. Due to variable follow-up periods, I was not able to confirm reproducibility of all the VF defects included in our study. 101 In addition to the potential follow-up work described in previous sections, recent evidence for a protective role for endogenous and/or exogenous estrogen against POAG development raises the interesting question of whether AT16 (inferior paracentral defect) may be associated specifically with postmenopausal status in women. 102 [32] [33] [34] [35] There has been much recent interest in developing diagnostic and prognostic combined structure-function indices for glaucoma. [109] [110] [111] Finally, an important feature of VF archetypal analysis is its inclusion of a broad range of VF defect etiologies, including those secondary to neurologic comorbidities (e.g., stroke) and VF testing artifacts (e.g., lens rim artifact and lid ptosis). The more we learn about the distinguishing features and underlying causes associated with different VF ATs, the more powerful VF archetypal decomposition will be as a diagnostic aid for elucidating and independently tracking different VF components for patients with complex VF defects caused by superposition of multiple etiologies. In glaucoma, the ability to monitor and intervene as needed for components corresponding to glaucomatous VF loss may have substantial therapeutic benefit. Going beyond glaucoma, similar analyses in more heterogeneous patient populations will likely yield new associations with VF ATs secondary to other important ocular and neurologic etiologies, further improving the content validity and clinical utility of VF archetypal analysis. 
